Cantor Fitzgerald Starts Humacyte (HUMA) at Overweight; Sees 100%+ Upside
Tweet Send to a Friend
(Updated - June 22, 2023 9:16 AM EDT)
Cantor Fitzgerald analyst Kristen Kluska initiates coverage on Humacyte (NASDAQ: HUMA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cantor Fitzgerald analyst Kristen Kluska initiates coverage on Humacyte (NASDAQ: HUMA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
